- Home
- NBIX vs DOCS Comparison
NBIX vs DOCS Comparison
Compare NBIX & DOCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBIX
- DOCS
- Stock Information
- Founded
- NBIX 1992
- DOCS 2010
- Country
- NBIX United States
- DOCS United States
- Employees
- NBIX N/A
- DOCS N/A
- Industry
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- DOCS Retail: Computer Software & Peripheral Equipment
- Sector
- NBIX Health Care
- DOCS Technology
- Exchange
- NBIX Nasdaq
- DOCS Nasdaq
- Market Cap
- NBIX 12.0B
- DOCS 13.2B
- IPO Year
- NBIX 1996
- DOCS 2021
- Fundamental
- Price
- NBIX $123.02
- DOCS $52.06
- Analyst Decision
- NBIX Strong Buy
- DOCS Buy
- Analyst Count
- NBIX 20
- DOCS 16
- Target Price
- NBIX $163.20
- DOCS $61.00
- AVG Volume (30 Days)
- NBIX 1.6M
- DOCS 3.5M
- Earning Date
- NBIX 05-05-2025
- DOCS 05-15-2025
- Dividend Yield
- NBIX N/A
- DOCS N/A
- EPS Growth
- NBIX N/A
- DOCS 54.17
- EPS
- NBIX 2.96
- DOCS 1.11
- Revenue
- NBIX $2,412,600,000.00
- DOCS $570,399,000.00
- Revenue This Year
- NBIX $15.99
- DOCS $13.48
- Revenue Next Year
- NBIX $14.93
- DOCS $12.17
- P/E Ratio
- NBIX $41.60
- DOCS $46.93
- Revenue Growth
- NBIX 21.73
- DOCS 19.98
- 52 Week Low
- NBIX $84.23
- DOCS $25.00
- 52 Week High
- NBIX $157.98
- DOCS $85.21
- Technical
- Relative Strength Index (RSI)
- NBIX 62.85
- DOCS 40.60
- Support Level
- NBIX $117.59
- DOCS $51.35
- Resistance Level
- NBIX $125.63
- DOCS $52.80
- Average True Range (ATR)
- NBIX 2.98
- DOCS 2.11
- MACD
- NBIX -0.02
- DOCS -0.42
- Stochastic Oscillator
- NBIX 72.90
- DOCS 27.93
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About DOCS Doximity Inc.
Doximity Inc is a digital platform for U.S. medical professionals. Its cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers.